Newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep brain reward circuit. The finding could open new avenues for understanding food cravings and potentially treating substance use disorder.
Most Read
read also
دعم طبي جديد بالبحيرة.. 16 سري...
23 July, 2026
بشير التابعي: تأخر إعداد الزما...
22 July, 2026
New plugin unlocks granular VR...
21 July, 2026
Why Ocon is upbeat after Haas...
25 July, 2026
ترامب يكشف موقف موسكو وبكين من...
24 July, 2026